Low-dose whole-skin radiation for relapsed skin lymphoma
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This trial studies a lower-dose radiation treatment that treats the whole skin to help people with mycosis fungoides that has come back or did not respond to prior treatment. If you qualify, it may offer another option when other therapies have stopped working.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your diagnosis is confirmed by a skin biopsy as mycosis fungoides (stage IB to IIIA).
- Your skin disease has either not responded (refractory) or has come back (relapsed) after at least one prior treatment, such as topical steroids.
- You are expected to live more than 6 months.
- You do not have a serious medical problem that would make radiation unsafe for you.
- You are not pregnant and not breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether ultra low-dose radiation can control specific skin lesions from mycosis fungoides (a type of lymphoma that affects the skin). It may help shrink or control targeted spots while using a lower radiation amount.
This Phase 3 study tests a low-dose skin radiation treatment (electron beam) to help eradicate the harmful cancer cells in early-stage mycosis fungoides. It may be an option if you have stage IB or IIA disease and can safely undergo the required light/radiation preparation steps.
This Phase 2 trial studies whether giving very low-dose total-skin electron beam radiation at the same time as brentuximab vedotin can control mycosis fungoides (a lymphoma that affects the skin). It’s for people whose disease has returned or hasn’t responded to prior treatment, especially if the tumor marker CD30 is present.
This early-stage study tests whether a cancer-killing cream (imiquimod) combined with targeted local radiation can shrink and control mycosis fungoides skin lesions. It may help people whose skin lymphoma has not responded to at least one prior standard treatment.
This trial tests a treatment called photopheresis to treat early-stage mycosis fungoides, a type of skin lymphoma. It may help reduce or control skin patches or plaques that have not responded well to standard treatments.
This trial tests a cream applied to the skin that may help control early-stage mycosis fungoides, a type of skin lymphoma. It aims to see if the cream can reduce symptoms and slow disease progression without the need for stronger treatments.
Hear when a new Recurrent Mycosis Fungoides trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.